To Top

Issue:

Q2 2018

25 Articles available
Hot Melt Extrusion

Leveraging Hot Melt Extrusion for Solubility and Continuous Manufacturing

PAP-Q2-18-CL-007
Mergers & Acquisitions

Inside Mergers & Acquisitions

PAP-Q2-18-CL-001
Next-Generation Biopharma

Changes in the Biopharma Industry: from Minor to Major Evolution

PAP-Q2-18-NI-002
Clinical Trials

Supporting Patient-Centric Clinical Trials from Point-of-Origin through the Last Mile

PAP-Q2-18-CL-002
Investment

Taking Middle-Market CROs and CDMOs to the Next Level

PAP-Q2-18-CL-003
Biologic Candidates

Addressing Development Challenges for Complex Biologic Drug Candidates

PAP-Q2-18-CL-004
Viral Vector

Flexible, Mobile, Modular: High-Containment Viral Vector Center of Excellence

PAP-Q2-18-CL-005
Contract Manufacturing Needs

Meeting Biopharma Contract Manufacturing  Needs with a Flexible  Global Network

PAP-Q2-18-CL-006
Biologics

Building a Biologics Business from the Ground Up

PAP-Q2-18-CL-008
Multi-Product Facility Manufacturing

Using a Risk-Based Approach to Manufacturing in a Multi-Product Facility

PAP-Q2-18-CL-009
GMP

State-of-the-Art Biologics Manufacturing in an Unexpected Location

PAP-Q2-18-CL-010
Cell and Gene Therapy

Overcoming Raw Material and Supply Chain Challenges in Viral Vector Manufacturing

PAP-Q2-18-CL-011
OSD Facility Design

Modern OSD Facility Design Considerations for Operational Efficiency and Regulatory Compliance

PAP-Q2-18-CL-012
Integration

Strengthening the Outsource Service Offering through Integration

PAP-Q2-18-CL-013
Corporate Social Responsibility

Corporate Social Responsibility as a Driver for Improved Sustainability

PAP-Q2-18-CL-014
Next-Generation Drug Development

Challenges for Next-Generation Biological Therapeutics Discovery and Development

PAP-Q2-18-FA-001
Next-Generation Manufacturing

Thinking a Generation Ahead: Biologics-Based Therapy

PAP-Q2-18-FA-002
Next-Generation Packaging

Finishing Touches – The Future of Fill-Finish and Pharma Packaging

PAP-Q2-18-FA-003
Asset Management

Maximizing ROI through Equipment Liquidation

PAP-Q2-18-CL-015
Solid Oral Dosage Drugs

Experience Meets Flexibility

PAP-Q2-18-CL-016
Oral Peptides

Scientific Expertise Facilitates Oral Peptide Product Development and Manufacturing

PAP-Q2-18-CL-017
Controlled Nucleation

Achieving Controlled Nucleation During Aseptic Lyophilization

PAP-Q2-18-CL-018
Market Expansion

BioPharma CDMO Success Requires Technical Leadership and Problem-Solving Capabilities

PAP-Q2-18-CL-019
Fill-Finish Services

Providing Flexible Capabilities to Meet Market Demand for Sterile Fill-Finish Services

PAP-Q2-18-CL-020
Substance Control

DOPING – Famous Cases, Substances and Values in Sports

PAP-Q2-18-NI-003